+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Synthetic Bone Graft Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 133 Pages
  • May 2023
  • Region: Global
  • GlobalData
  • ID: 5821004
The publisher's Medical Devices sector report, 'Synthetic Bone Graft Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Synthetic Bone Graft Substitutes pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Synthetic bone graft substitutes are used as substitutes to autograft and allograft bone.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Synthetic Bone Graft Substitutes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Synthetic Bone Graft Substitutes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Synthetic Bone Graft Substitutes under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
2 Introduction
2.1 Synthetic Bone Graft Substitutes Overview
3 Products under Development
3.1 Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development
3.2 Synthetic Bone Graft Substitutes - Pipeline Products by Territory
3.3 Synthetic Bone Graft Substitutes - Pipeline Products by Regulatory Path
3.4 Synthetic Bone Graft Substitutes - Pipeline Products by Estimated Approval Date
3.5 Synthetic Bone Graft Substitutes - Ongoing Clinical Trials
4 Synthetic Bone Graft Substitutes - Pipeline Products under Development by Companies
4.1 Synthetic Bone Graft Substitutes Companies - Pipeline Products by Stage of Development
4.2 Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development
5 Synthetic Bone Graft Substitutes Companies and Product Overview6 Synthetic Bone Graft Substitutes- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development
  • Synthetic Bone Graft Substitutes - Pipeline Products by Territory
  • Synthetic Bone Graft Substitutes - Pipeline Products by Regulatory Path
  • Synthetic Bone Graft Substitutes - Pipeline Products by Estimated Approval Date
  • Synthetic Bone Graft Substitutes - Ongoing Clinical Trials
  • Synthetic Bone Graft Substitutes Companies - Pipeline Products by Stage of Development
  • Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development
  • Synthetic Bone Graft Substitutes - Pipeline Products by Territory
  • Synthetic Bone Graft Substitutes - Pipeline Products by Regulatory Path
  • Synthetic Bone Graft Substitutes - Pipeline Products by Estimated Approval Date
  • Synthetic Bone Graft Substitutes - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Acuitive Technologies Inc
  • Agenta Biotechnologies Inc (Inactive)
  • Amend Surgical, Inc.
  • Anika Therapeutics Inc
  • Baxter International Inc
  • Berkeley Advanced Biomaterials Inc
  • Bio2 Technologies Inc
  • BioGend Therapeutics Co Ltd
  • Biomatlante SA
  • Biorez Inc
  • BonAlive Biomaterials Ltd.
  • Bone Solutions Inc
  • BoneGrafix, Inc.
  • BoneSupport AB
  • Calcitec, Inc.
  • Daewoong Pharmaceutical Co Ltd
  • Dimension Inx LLC
  • DSM Biomedical BV
  • Elute Inc
  • Eskisehir Osmangazi University
  • EternoGen Aesthetics LLC
  • Graftys SA
  • Industrie Biomediche Insubri SA
  • Innovoss Inc. (Inactive)
  • IRCCS San Raffaele Hospital
  • Isto Biologics
  • King's College London
  • Maxigen Biotech Inc
  • National Center of Innovation for Biomaterials in Orthopaedic Research
  • National University of Science and Technology MiSiS
  • OrthoMedex LLC
  • PolyPid Ltd
  • Polytechnic University of Catalonia
  • Promimic AB
  • ReCaPP
  • RepRegen Ltd. (Inactive)
  • Revivicor Inc
  • Sanara MedTech Inc
  • Scil Technology GmbH
  • SDIP Innovations Pty Ltd
  • SIRAKOSS Ltd
  • Sofregen Medical Inc
  • Soteira Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • SurGenTec LLC
  • University of California San Diego
  • University of Edinburgh
  • Wright Medical Group NV (Inactive)
  • Xtant Medical Holdings Inc